Sign in
4

Changes in Ownership

Arbutus Biopharma Corp Filed Acc 0001447028-25-000072

Options or other derivatives

  • President and CEO acquired 310,422 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Androski Lindsay · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-03-18 Grant or award : show line 1 in the form Stock Option (Right to Buy) +310,422 310,422 D
Loading xslF345X05/wk-form4_1742501306.xml…